Boston Scientific (BSX) PT Raised to $21 at Leerink Partners Following Q1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Boston Scientific (BSX) Reports In-Line Q1 EPS
April 28, 2015 7:01 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.78 billion.
Boston Scientific sees FY2015 EPS of $0.88-$0.92, versus the consensus of $0.91. Boston Scientific sees FY2015 revenue... More
